Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Leal James, Vice-Président Senior. Director active across 2 companies, notably TANDEM DIABETES CARE INC. In total, 28 reports have been published. History available since 28 June 2021. The latest transaction was disclosed on 28 May 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Leal James
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3,574 shares@ US$82.3428.8% of flowCommon StockSEC:0001438133-21-000163:0
25 of 28 declarations
About Leal James
Leal James is Senior Vice President and Chief Manufacturing Officer at Tandem Diabetes Care INC (XNAS). He has 28 filings in total, and across the sampled recent filings in these data, the most frequent transaction nature is option exercise, with a date range from 2021-06-30 to 2024-05-28.